<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00361725</url>
  </required_header>
  <id_info>
    <org_study_id>PROCAS</org_study_id>
    <nct_id>NCT00361725</nct_id>
  </id_info>
  <brief_title>Comparative Study of the Protein C Pathway in Septic and Non Septic Patients With Organ Failure</brief_title>
  <official_title>Comparative Study of the Protein C Pathway in Septic and Non Septic Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique - Hôpitaux de Paris</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Institut National de la Santé Et de la Recherche Médicale, France</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Assistance Publique - Hôpitaux de Paris</source>
  <brief_summary>
    <textblock>
      This is a comparative study performed in 3 groups of patients/subjects: 30 severe sepsis
      patients, 30 non-septic patients with organ failure, 30 healthy subjects.

      The only intervention is a venous blood sampling at the onset of the disease.

      The purpose of the study is to compare the PC pathway and expression and inflammatory genes
      between the 3 groups. The main hypothesis is that systemic inflammatory response and
      exacerbated coagulation activation are non specific of an infection as a triggering event.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      analysis of the PC pathway

        -  PC activity

        -  PS activity

        -  soluble thrombomodulin

        -  soluble EPCR

        -  activated protein C

        -  quantitative flow cytometry on monocytes (thrombomodulin and EPCR)

        -  whole blood mRNA (Tissue factor, thrombomodulin and EPCR)

        -  inflammatory gene expression analysis by MLPA
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <start_date>March 2003</start_date>
  <completion_date>October 2003</completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control, Natural History</observational_model>
    <time_perspective>Cross-Sectional, Prospective</time_perspective>
  </study_design_info>
  <enrollment>90</enrollment>
  <condition>Severe Sepsis</condition>
  <condition>Organ Failure</condition>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  severe sepsis patients or:

          -  non-septic acute organ failure patients or:

          -  healthy subjects matched for age and sex with severe sepsis patients

        Exclusion Criteria:

          -  criteria for organ failure lasting for more than 24 hours
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jean-Luc DIEHL, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assistance Publique - Hôpitaux de Paris</affiliation>
  </overall_official>
  <results_reference>
    <citation>Borgel D, Clauser S, Bornstain C, Bièche I, Bissery A, Remones V, Fagon JY, Aiach M, Diehl JL. Elevated growth-arrest-specific protein 6 plasma levels in patients with severe sepsis. Crit Care Med. 2006 Jan;34(1):219-22.</citation>
    <PMID>16374177</PMID>
  </results_reference>
  <verification_date>June 2006</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 7, 2006</study_first_submitted>
  <study_first_submitted_qc>August 7, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 8, 2006</study_first_posted>
  <last_update_submitted>August 9, 2006</last_update_submitted>
  <last_update_submitted_qc>August 9, 2006</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 15, 2006</last_update_posted>
  <keyword>severe sepsis</keyword>
  <keyword>organ failure</keyword>
  <keyword>activated protein C</keyword>
  <keyword>thrombomodulin</keyword>
  <keyword>EPCR</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sepsis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Protein C</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

